PRIORIX TETRA

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Hong Kong, Ireland, Lithuania, Malta, New Zealand, Poland, Singapore, South Africa

Active ingredients

The drug PRIORIX TETRA contains a combination of these active pharmaceutical ingredients (APIs):

1 Measles vaccine, Schwarz strain 1000
Read about Measles, live attenuated
2 Mumps virus, live attenuated, RIT 4385
Read about Mumps, live attenuated
3 Rubella virus, Wistar RA27/3 strain 1000
UNII 52202H034Z - RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN

Rubella virus vaccine contains live attenuated rubella virus, produced in human diploid (MRC-5) cells. It is a virus vaccine for active immunization against rubella that is subcutaneously administered.

Read about Rubella, live attenuated
4 Varicella virus live attenuated OKA
UNII GPV39ZGD8C - VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN

Natural infection induces a cellular and humoral immune response to the varicella-zoster virus, which can be rapidly detected following infection. IgG, IgM and IgA directed against viral proteins usually appear at the same time that a cellular immune response can be demonstrated, making the relative contribution of humoral and cellular immunity to disease progression difficult to ascertain. Vaccination has been shown to induce both humoral and cell-mediated types of immunity.

Read about Varicella, live attenuated

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BD Measles vaccines
Discover more medicines within J07BD54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510611701153411, 510618090060207
Country: CA Health Products and Food Branch Identifier(s): 02297884
Country: EE Ravimiamet Identifier(s): 1277489, 1277490, 1277502, 1277513, 1277861, 1277872, 1277883
Country: HK Department of Health Drug Office Identifier(s): 57798
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1024239, 1024240, 1024466, 1024758, 1026808, 1026809, 1026810, 1026811, 1065761
Country: MT Medicines Authority Identifier(s): MA170/01002, MA170/01003
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11761
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100182334, 100182357
Country: SG Health Sciences Authority Identifier(s): 13627P
Country: ZA Health Products Regulatory Authority Identifier(s): 43/30.1/0127

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.